Avoid Condition Case Studies

Upon reviewing the given case study following factors identified, that the condition status: progressive
Risk factor: age 23 yr. (young age), woman
Observation: ptosis, sneering while smiling Reflexes: within normal limits Sensation: Within normal limits Weakness of the bilateral arm increased after exercise
Symptoms: Intermittent facial muscular weakness, diplopia in late evening, dysphagia, and bilateral weakness increased after strenuous activity
On behalf of the available information most probably condition could be a Nero, muscular disorder, Myasthenia Gravis .Condition could be confirmed by diagnostic test such as Tension Test, electromyography and presence of

Acetylcholine normally transmits signals between nerves and muscles, so when its receptors are destroyed it cannot induce muscle contractions. No cure for the disease yet exists. Treatment of MG is based on four different options which take different amounts of time before muscular weakness will improve ,improvement of neuromuscular transmission by acetylcholine esterase inhibitors, e.g. pyridostigmine .treatment of acute exacerbations (plasmapheresis, immunoadsorption, intravenous immunoglobulin) • immunosuppression , thymectomy. but it can be treated with drugs, called anticholinesterases, that inhibit an enzyme, acetylcholinesterase, that breaks down acetylcholine in the body leads to increase muscular strengthens inhibitors do not cure diseases only symptomatic relief. With optimal treatment, the prognosis is good in terms of daily functions, quality of life and survival in the majority of patients suffering from MG. Symptomatic treatment with acetylcholine esterase inhibition is usually combined with immunosuppression. Pyridostigmine bromide is still the most commonly used acetylcholinesterase inhibitor in the treatment of MG. Plasmapheresis, immunoadsorption and the intravenous administration of immunoglobulins, respectively, are used for crisis intervention. The current MG therapy were already introduced more than 40 years ago. These are still pyridostigmine, corticosteroids, azathioprine and thymectomy. However, first experiences with new drugs, e.g. rituximab, are highly